How much funding has Therapixel raised?

Therapixel has raised $25.6M in total funding, most recently a Series B round.

Who are Therapixel's investors?

Therapixel's investors include Crédit Mutuel Innovation, CapHorn Invest, Omnes Capital, M Capital Partners, Elaia, VERVE CAPITAL.

When was Therapixel founded?

Therapixel was founded in 2013.

Where is Therapixel headquartered?

Therapixel is headquartered in Nice, France.

What industry is Therapixel in?

Therapixel operates in Artificial Intelligence, Healthcare.

How many employees does Therapixel have?

Therapixel has 11-50 employees.

Therapixel

Innovation in medical imaging accessible to all

Nice, France · Founded 2013 · $25.6M raised

Artificial Intelligence

Healthcare

Headquarters: Nice
Employees: 11–50
Founded: 2013
Business Model: B2B

Website: therapixel.com
Total Funding: $25.6M
Last Round: $16.5M Series BJan 2023
Rounds: 3

About

Therapixel is a French AI company founded in 2013 and headquartered in Nice, specializing in artificial intelligence applied to medical imaging with a focus on breast cancer detection. The company's flagship product, MammoScreen, is an FDA-cleared and CE-marked AI software that assists radiologists in reading mammograms, having been built on algorithms that won the prestigious DREAM Digital Mammography Challenge in 2017 — a competition of nearly 1,200 global research teams. MammoScreen has been adopted by leading institutions including Mayo Clinic and is commercially deployed across Europe and North America, helping radiology practices improve cancer detection rates while managing growing screening volumes without adding reader capacity.

Summary

Therapixel is an Artificial Intelligence company based in Nice, France, founded in 2013. It has raised $25.6M in total across 3 rounds, most recently a $16.5M Series B round in Jan 2023. Investors include Crédit Mutuel Innovation, CapHorn Invest and Omnes Capital.